Viewing Study NCT04339595


Ignite Creation Date: 2025-12-24 @ 1:12 PM
Ignite Modification Date: 2025-12-28 @ 12:26 AM
Study NCT ID: NCT04339595
Status: TERMINATED
Last Update Posted: 2021-12-08
First Post: 2020-03-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Long-Term Treatment Effect With Tildrakizumab in Participants With Plaque Psoriasis
Sponsor: Almirall, S.A.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module